This Week in Healthcare Funding

Based in Irvine, Ca., CG Oncology , a company with 13 years under its belt, is at the forefront of developing treatments for non-muscle invasive bladder #cancer. They recently attracted a $105 million funding round, jointly helmed by Foresite Capital and TCGX . Other significant participants in this round included Avidity Partners , BVF PARTNERS, L.P , Janus Henderson Investors , Acorn Bioventures , Ally Bridge Group , Decheng Capital , Longitude Capital , Malin Corporation, and RA Capital Management . To date, CG #Oncology has garnered investments totaling $317.6 million.

Tampa, Fl.-based Healthmap Solutions , a startup with seven years of operation, asserts it has pioneered technology combining predictive analytics and clinical expertise for early kidney disease detection. This innovation aims to suggest evidence-based interventions to postpone or mitigate disease advancement. The company recently secured $100 million in funding, with WindRose Health Investors taking the lead from prior investments. In total, Healthmap Solutions has amassed $225.6 million in investments.

Burlington, Ma.-based LightForce Orthodontics, a startup with eight years in the industry specializing in customized 3D printed braces, recently secured an $80 million Series D investment. Ally Bridge Group , Transformation Capital , and Care Capital jointly led this round. Omega Venture Partners , Matter Venture Partners, Delta Dental Ins. of California, and the American Association of Orthodontics contributed. To date, LightForce #Orthodontics has accumulated funding of $150.6 million.

Kyverna Therapeutics , an Emeryville, Ca.-based startup established five years ago focusing on cell-based treatments for autoimmune disorders like #lupus, recently secured a $60 million Series B extension funding round. This round was jointly spearheaded by Bain Capital Life Sciences and GordonMD? Global Investments LP . Earlier investors such as Gilead Sciences , Westlake BioPartners? , Vida Ventures, LLC , Northpond Ventures , RTW Investments, LP , Insight Partners , CAMCapital , LYFE Capital , and jVen Capital LLC also joined. So far, Kyverna Therapeutics has attracted $170 million in investments.

TytoCare , an Israeli firm established 11 years ago, offers #telehealth services through a device that collects data from its otoscope, tongue depressor, thermometer, and stethoscope. The company recently secured $49 million in funding, spearheaded by its prior backer, Insight Partners . New participants in this round included MemorialCare , HOOPP (Healthcare of Ontario Pension Plan) and CLAL . To date, TytoCare has amassed $205.7 million in funding.

Amber Bio , a #biotech startup from San Francisco established two years ago, harnesses Crispr gene-editing technology to target RNA. The company believes this approach might address a wider range of genetic diseases more safely than DNA gene editing. Recently, they secured $26 million in a seed funding round jointly led by Playground Global and Andreessen Horowitz . Other contributors to this round included 礼来 , Retinal Degeneration Fund , Hummingbird Ventures , and Pillar VC .

Based in Larkspur, Ca., Aulos Bioscience , a biotech startup established three years ago, is working on treatments to guide the immune systems of cancer patients in targeting and eliminating tumor cells. They recently secured $20 million in a Series A extension funding round, with ATP (Apple Tree Partners) as the investor. Overall, Aulos Bioscience has attracted $60 million in investments.

Entia , a London-based startup established nine years ago, provides at-home blood testing for patients undergoing cancer therapies. They recently secured a $20 million Series A investment, with BGF and Parkwalk Advisors taking the lead. To date, Entia has accumulated $35.7 million in funding.

VenoStent, Inc. , a six-year-old #startup from Houston, is innovating a device to enhance the functionality and longevity of surgically made artery-vein connections in the arms of chronic kidney disease sufferers. The company recently obtained $16 million in a Series A funding round. The round was jointly led by Good Growth Capital and IAG Capital Partners and saw contributions from entities like TMC Venture Fund, SNR , Baylor Angel Network / Affinity Fund, Creative Ventures , Cowtown Angels , and Alumni Ventures . In total, VenoStent has raised $22.2 million in investments.

Swiss-based EPITERNA , working on small molecule drugs designed to decelerate aging—first for dogs and eventually for humans—recently secured $11.1 million in funding. Prima Materia spearheaded the investment round.

Remedial Health (YC W22) , a Nigerian enterprise offering a digital platform for pharmacies and hospitals to order medications, recently attracted $8 million in Series A funding and an additional $4 million in venture debt. The financial push was led by QED Investors , bringing the company's cumulative funding to $17.4 million.

New York-based Uptiv Health , focusing on crafting personalized infusion care therapy for those battling chronic ailments, recently attracted $7.5 million in a seed funding round. Redesign Health was among the key investors.

FeelBetter , a five-year-old startup with operations in Boston and Tel Aviv specializing in medication management technology, recently secured $5.9 million in investments. Firstime Ventures and Shoni Health Ventures spearheaded the funding round. Additional contributors included Random Forest VC , The Group Ventures , and Triventures , an existing investor. To date, FeelBetter has amassed $8 million in funding.

BrainTale , a Paris-based startup established five years ago, focuses on creating and distributing diagnostic and prognostic tools that analyze white matter to facilitate improved brain care. They recently secured $4.9 million in funding, with Capital Grand Est and GROUPE MACSF jointly leading the investment round. So far, BrainTale has amassed $6.1 million in investments.

Béa Fertility , a London-based startup founded three years ago with a mission to offer clinical-grade #fertility care in the comfort of one's home, recently garnered a $3.2 million investment round. Octopus Ventures spearheaded the funding and saw contributions from JamJar Investments , Forward Partners , Calm/Storm , and QVentures . Overall, Béa Fertility has attracted $4.3 million in investments.

Eagan, Mn.-based Pelvital has developed an FDA-approved intravaginal device for home use to address stress urinary incontinence and weakened pelvic floor muscles. The startup recently secured a $2.68 million seed funding round spearheaded by Boomerang Ventures . VisionTech Partners | VisionTech Angels and Wisconsin Investment Partners also participated in the round.

A Chicago-based company named AMOpportunities , which has been operational for ten years and specializes in overseeing clinical training for schools, hospitals, and students, recently secured a $2 million Series A extension round of funding. Backers for this round included Laerdal Million Lives Fund and LAGO Innovation Fund . Overall, the company has garnered $11.8 million in investments.

New Funds

Yosemite - Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments. Investors include prominent individuals and institutions, including 美国麻省理工学院 ,? 纪念斯隆-凯特琳癌症中心 , and John Doerr .